IOBT
IO Biotech, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website iobiotech.com
- Employees(FY) 57
- ISIN US4497781090
Performance
+2.74%
1W
-5.06%
1M
-16.2%
3M
+53.85%
6M
-20.21%
YTD
-26.83%
1Y
Profile
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
Technical Analysis of IOBT 2024-05-03
Overview:
In analyzing the technical indicators for IOBT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-04-24 04:30
- 2024-04-14 20:30
- 2024-04-09 00:00
- 2024-04-04 20:30
- 2024-04-04 20:30
- 2024-03-07 01:01
- 2024-03-06 03:11
- 2024-03-05 09:52
IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023(Investorplace)
- 2024-03-05 03:40
- 2024-02-26 03:05
- 2023-12-20 19:30
- 2023-11-12 19:12
IO Biotech Announces 2023 Third Quarter Results(Globenewswire)
- 2023-11-12 19:00
- 2023-11-09 19:00
- 2023-11-08 03:30
- 2023-10-31 20:30
- 2023-10-24 00:30
- 2023-10-22 13:00
- 2023-10-03 04:30
- 2023-09-11 20:05
- 2023-09-05 20:35
- 2023-08-16 20:59
10 Best New Penny Stocks to Buy Now(Yahoo Finance)
- 2023-08-16 09:01
- 2023-08-10 20:30
IO Biotech Announces 2023 Second Quarter Results(Yahoo Finance)
- 2023-08-10 20:05
IO Biotech Appoints Heidi Hunter to its Board of Directors(Yahoo Finance)
- 2023-08-07 20:05
- 2023-08-06 20:30
- 2023-07-27 20:05
- 2023-07-25 04:05
- 2023-07-18 04:05
Page 1 of 3
previousnext